Effectiveness and Implementation of mPATH-CRC: a Mobile Health System for Colorectal Cancer Screening

mPATH-CRC 的有效性和实施:用于结直肠癌筛查的移动医疗系统

基本信息

  • 批准号:
    10165873
  • 负责人:
  • 金额:
    $ 22万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-06-01 至 2021-05-31
  • 项目状态:
    已结题

项目摘要

Abstract As outlined in the NIH Strategic Plan for Data Science, recent advances in computing technology have improved the ability to create interoperable and scalable electronic health record (EHR) integrated software using WebServices (e.g., application programming interfaces, APIs) and cloud-based computing architecture. The current leading standard for health care data exchange is Fast Health Interoperability Resources (FHIR), published by the HL7® working group. FHIR is a specification that provides standardized data models and APIs for managing health care data, and represents a simplification and expansion of earlier HL7 standards. The SMART on FHIR standard allows the integration of apps within a clinical workflow, including contextual embedding, authorization, and single sign-on. As technology evolves, EHRs have increasingly adopted more of a platform role, enabling third-party applications to perform limited functions within the system of record. Interoperable standards-based information systems that facilitate the secure but agile exchange of data are critical to contemporary healthcare delivery. Cloud-based services are widely used in the non-healthcare domain. EHR-integrated digital and mobile health applications must include expanded use of the SMART on FHIR standard and cloud base architecture to allow for scalability and ease of installation across healthcare systems and care settings. Our team, which includes board-certified clinical informaticists and Epic-certified programmers, has deep expertise creating multilevel digital health interventions that target the patient, clinician, and healthcare system to increase the uptake of guideline-recommended cancer screening. In a prior multisite randomized controlled trial, our highly successful mPATHTM-CRC (mobile PAtient Technology for Health-Colorectal Cancer) iPad app doubled the proportion of patients who were screened for colorectal cancer. We are currently conducting a hybrid implementation- effectiveness trial of mPATHTM-CRC in 28 community-based clinics (R01CA218416-A1). As part of the parent award, we determined the best way to integrate mPATHTM-CRC in clinical workflow. We then spent 9 months converting mPATHTM- CRC from a stand-alone iPad app to one that is fully-integrated with Wake Forest’s Epic EHR. To date, we have launched the new EHR-integrated mPATHTM program in 6 of our planned 28 clinics. Prior to COVID-19, over 15,000 patients had used mPATHTM, which identified over 1100 patients who were overdue for CRC screening by a mean of 10 years. The specific aims of this supplement are to: (1) Enhance the mPATHTM-CRC application’s interoperability and decrease EHR- vendor specific dependencies by leveraging WebServices and SMART on FHIR; (2) re-engineer mPATHTM-CRC from a containerized, on-premise architecture to a service-agnostic cloud-based architecture; and (3) validate the interoperable (SMART on FHIR leveraging OAUTH2.0) and cloud-based architecture through rigorous testing. Achieving these aims will greatly increase the impact of the platform and contribute to the literature for open-standards based software development. Additionally, this project will yield essential information for the successful implementation of other technology-mediated interventions in healthcare settings.
摘要 正如NIH数据科学战略计划所概述的那样,计算技术的最新进展改善了 能够使用WebServices创建可互操作和可扩展的电子健康记录(EHR)集成软件 (e.g.,应用程序编程接口(API)和基于云的计算架构。当前领先的标准 快速健康互操作性资源(FHIR)是由HL 7 ®工作组发布的。 FHIR是一种规范,它提供了用于管理医疗保健数据的标准化数据模型和API,并代表了 简化和扩展早期的HL 7标准。SMART on FHIR标准允许将应用程序集成到 临床工作流程,包括上下文嵌入、授权和单点登录。随着技术的发展, 越来越多地采用更多的平台角色,使第三方应用程序能够在 记录系统。可互操作的基于标准的信息系统,促进安全但灵活的 数据对于当代医疗保健服务至关重要。基于云的服务广泛用于非医疗保健领域 域EHR集成的数字和移动的健康应用程序必须包括在FHIR上扩展SMART的使用 标准和基于云架构,以实现跨医疗保健系统和护理的可扩展性和易于安装性 设置.我们的团队,包括董事会认证的临床信息学家和Epic认证的程序员, 专业知识,创建多层次的数字健康干预措施,针对患者,临床医生和医疗保健系统, 增加指南推荐的癌症筛查的接受率。在之前的一项多中心随机对照试验中, 非常成功的mPATHTM-CRC(移动的健康-结直肠癌患者技术)iPad应用程序使 接受结直肠癌筛查的患者比例。我们目前正在进行混合实施- 在28家社区诊所开展的mPATHTM-CRC有效性试验(R 01 CA 218416-A1)。作为家长奖的一部分,我们 确定了在临床工作流程中整合mPATHTM-CRC的最佳方式。然后我们花了9个月的时间转换mPATHTM- CRC从一个独立的iPad应用程序到一个完全集成了维克森林的史诗EHR。到目前为止,我们已经推出了 在我们计划的28个诊所中的6个诊所实施新的EHR整合mPATHTM计划。在COVID-19之前,超过15,000名患者 使用mPATHTM,确定了超过1100名平均逾期10年未进行CRC筛查的患者。的 本补充的具体目标是:(1)增强mPATHTM-CRC应用程序的互操作性,减少EHR- 通过在FHIR上利用WebServices和SMART,实现特定于供应商的依赖关系;(2)从 容器化的内部部署架构转变为与服务无关的基于云的架构;以及(3)验证 (SMART on FHIR,利用OHOS 2.0)和基于云的架构。实现这些目标将 大大增加平台的影响力,并为基于开放标准的软件的文献做出贡献 发展此外,该项目将为成功实施其他 在医疗保健环境中进行技术干预。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David P Miller其他文献

Color Doppler and two-dimensional echocardiographic determination of the mechanism of aortic regurgitation with surgical correlation.
彩色多普勒和二维超声心动图测定主动脉瓣关闭不全的机制与手术的相关性。
Long‐Term Protection from Myocardial Ischemic Events in a Randomized Trial of Brief Integrin β3 Blockade with Percutaneous Coronary Intervention
经皮冠状动脉介入治疗短暂整合素 β3 阻断的随机试验对心肌缺血事件的长期保护
  • DOI:
    10.1097/00132586-199808000-00009
  • 发表时间:
    1998
  • 期刊:
  • 影响因子:
    0
  • 作者:
    E. Topol;J. Ferguson;H. Weisman;J. Tcheng;S. Ellis;N. Kleiman;R. Ivanhoe;Ann L. Wang;David P Miller;K. Anderson;R. Califf
  • 通讯作者:
    R. Califf
Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology. EPIC and EPILOG Investigators. Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation of PTCA To Improve Long-term Outcome with abciximab GPIIb/IIIa Receptor Block
阿昔单抗对血管成形术并发症的减少很大程度上与基线病变形态无关。
  • DOI:
    10.1016/s0735-1097(98)00403-3
  • 发表时间:
    1998
  • 期刊:
  • 影响因子:
    24
  • 作者:
    Stephen G. Ellis;A. Lincoff;David P Miller;J. Tcheng;N. Kleiman;D. Kereiakes;R. Califf;E. Topol
  • 通讯作者:
    E. Topol
Benefit of early sustained reperfusion in patients with prior myocardial infarction (the GUSTO-I trial). Global Utilization of Streptokinase and TPA for occluded arteries.
早期持续再灌注对既往心肌梗塞患者的益处(GUSTO-I 试验)。
  • DOI:
  • 发表时间:
    1998
  • 期刊:
  • 影响因子:
    2.8
  • 作者:
    D. Brieger;K. Mak;H. White;N. Kleiman;David P Miller;A. Vahanian;A. Ross;R. Califf;E. Topol
  • 通讯作者:
    E. Topol
Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complication.
在一项短期整合素 β3 阻断联合经皮冠状动脉介入治疗的随机试验中,可长期预防心肌缺血事件。
  • DOI:
  • 发表时间:
    1997
  • 期刊:
  • 影响因子:
    0
  • 作者:
    E. Topol;J. Ferguson;H. Weisman;J. Tcheng;Stephen G. Ellis;N. Kleiman;R. Ivanhoe;Ann L. Wang;David P Miller;K. Anderson;R. Califf
  • 通讯作者:
    R. Califf

David P Miller的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David P Miller', 18)}}的其他基金

A cloud-based digital health navigation program for colorectal cancer screening
基于云的结直肠癌筛查数字健康导航程序
  • 批准号:
    10697474
  • 财政年份:
    2023
  • 资助金额:
    $ 22万
  • 项目类别:
A Personalized Digital Outreach Intervention for Lung Cancer Screening
肺癌筛查的个性化数字外展干预措施
  • 批准号:
    10551856
  • 财政年份:
    2020
  • 资助金额:
    $ 22万
  • 项目类别:
A Personalized Digital Outreach Intervention for Lung Cancer Screening
肺癌筛查的个性化数字外展干预措施
  • 批准号:
    10318171
  • 财政年份:
    2020
  • 资助金额:
    $ 22万
  • 项目类别:
A Personalized Digital Outreach Intervention for Lung Cancer Screening
肺癌筛查的个性化数字外展干预措施
  • 批准号:
    10062917
  • 财政年份:
    2020
  • 资助金额:
    $ 22万
  • 项目类别:
A Personalized Digital Outreach Intervention for Lung Cancer Screening
肺癌筛查的个性化数字外展干预措施
  • 批准号:
    9885242
  • 财政年份:
    2020
  • 资助金额:
    $ 22万
  • 项目类别:
Effectiveness and Implementation of mPATH-CRC: a Mobile Health System for Colorectal Cancer Screening
mPATH-CRC 的有效性和实施:用于结直肠癌筛查的移动医疗系统
  • 批准号:
    9895633
  • 财政年份:
    2018
  • 资助金额:
    $ 22万
  • 项目类别:
Effectiveness and Implementation of mPATH-CRC: a Mobile Health System for Colorectal Cancer Screening
mPATH-CRC 的有效性和实施:用于结直肠癌筛查的移动医疗系统
  • 批准号:
    10116309
  • 财政年份:
    2018
  • 资助金额:
    $ 22万
  • 项目类别:
Effectiveness and Implementation of mPATH-CRC: a Mobile Health System for Colorectal Cancer Screening
mPATH-CRC 的有效性和实施:用于结直肠癌筛查的移动医疗系统
  • 批准号:
    10382400
  • 财政年份:
    2018
  • 资助金额:
    $ 22万
  • 项目类别:
Institutional Career Development Core
机构职业发展核心
  • 批准号:
    10440530
  • 财政年份:
    2015
  • 资助金额:
    $ 22万
  • 项目类别:
Institutional Career Development Core
机构职业发展核心
  • 批准号:
    9902913
  • 财政年份:
    2015
  • 资助金额:
    $ 22万
  • 项目类别:

相似海外基金

EAGER: Toward a Decentralized Cross-administrator Zone Management System: Policy and Technology
EAGER:走向去中心化的跨管理员区域管理系统:政策和技术
  • 批准号:
    2331936
  • 财政年份:
    2023
  • 资助金额:
    $ 22万
  • 项目类别:
    Standard Grant
COLLABORATIVE RESEARCH: Social Influence in Eyewitness Identification Procedures: Do Blind Administrator Behaviors Magnify the Effects of Suspect Bias?
合作研究:目击者识别程序中的社会影响:盲目的管理员行为是否会放大嫌疑人偏见的影响?
  • 批准号:
    2043230
  • 财政年份:
    2021
  • 资助金额:
    $ 22万
  • 项目类别:
    Continuing Grant
COLLABORATIVE RESEARCH: Social Influence in Eyewitness Identification Procedures: Do Blind Administrator Behaviors Magnify the Effects of Suspect Bias?
合作研究:目击者识别程序中的社会影响:盲目的管理员行为是否会放大嫌疑人偏见的影响?
  • 批准号:
    2043334
  • 财政年份:
    2021
  • 资助金额:
    $ 22万
  • 项目类别:
    Continuing Grant
Making of the base for patient safety management skill of visiting nurse administrator by the web conference system
利用网络会议系统构建出诊护士管理者患者安全管理技能基础
  • 批准号:
    19K10768
  • 财政年份:
    2019
  • 资助金额:
    $ 22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of the nursing administrator training program to improve leadership behavior focused on emotional intelligence
制定护理管理人员培训计划,以改善以情商为重点的领导行为
  • 批准号:
    18K17464
  • 财政年份:
    2018
  • 资助金额:
    $ 22万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Automated Network Management that Dynamically Reflects Administrator Intent
动态反映管理员意图的自动化网络管理
  • 批准号:
    18K18038
  • 财政年份:
    2018
  • 资助金额:
    $ 22万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Administrator support perceived as useful for professional growth by novice psychiatric home-visit nursing staff
新手精神科家访护理人员认为管理员支持对专业成长有用
  • 批准号:
    17H07005
  • 财政年份:
    2017
  • 资助金额:
    $ 22万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
The Facts and Problems on Management of Public Museums: Validation of Designated Administrator System
公共博物馆管理的事实与问题:指定管理员制度的验证
  • 批准号:
    17K01212
  • 财政年份:
    2017
  • 资助金额:
    $ 22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A Study on Transformation of the School Administrator Preparation and Evaluation System in the United States
美国学校管理人员培养与评价体系转型研究
  • 批准号:
    26780449
  • 财政年份:
    2014
  • 资助金额:
    $ 22万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
The Family Court's Supervision of Property Administrator
家庭法院对财产管理人的监督
  • 批准号:
    26380108
  • 财政年份:
    2014
  • 资助金额:
    $ 22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了